eGFR — how to read your estimated kidney function, beyond "normal" or "low"
Paired condition: Type 2 diabetes labs
Quick answer
eGFR (estimated glomerular filtration rate) estimates how well your kidneys filter blood, calculated from your blood creatinine plus age and sex. It's the headline kidney-function number, but a single eGFR is easy to over-read: it can dip temporarily from dehydration, and chronic kidney disease is diagnosed on *persistence* (≥ 3 months) plus a urine test — not one blood draw. The urine albumin-to-creatinine ratio is the piece most people are missing.
Reference ranges and interpretation
| Value / population | Classification | What it means |
|---|---|---|
| ≥ 90 mL/min/1.73m² | G1 — normal or high | Normal filtration. Only counts as kidney disease if there's also a marker of damage (e.g., albuminuria). |
| 60 – 89 | G2 — mildly decreased | Often age-related; again, only 'disease' if a damage marker is present. |
| 45 – 59 | G3a — mild-to-moderate | The threshold where CKD is typically diagnosed even without other findings. |
| 30 – 44 | G3b — moderate-to-severe | Warrants closer monitoring and often nephrology input. |
| 15 – 29 | G4 — severely decreased | Advanced CKD; nephrology management. |
| < 15 | G5 — kidney failure | Kidney failure; dialysis or transplant considerations. |
eGFR stages (G1–G5) are from the KDIGO framework. A key nuance: eGFR 60–89 alone, without any marker of kidney damage, is not chronic kidney disease — it can simply reflect normal aging.
What eGFR is — and why creatinine alone isn't enough
What a single low eGFR does and doesn't mean
The 2021 race-free equation — why your number may have changed
What to look at alongside eGFR
- Cystatin C — a muscle-independent filtration marker for confirming borderline eGFR
- Blood pressure — both a cause and a consequence of kidney disease
- HbA1c / glucose — diabetes is the leading cause of CKD worldwide
- Electrolytes (potassium, bicarbonate) and phosphate — affected as function declines
- Trend over time — the slope of eGFR matters more than any single value
Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.
Start with my labs →Frequently asked questions
Is an eGFR of 60–89 kidney disease?
Not by itself. An eGFR in the 60–89 range without any marker of kidney damage (like albuminuria) is often just normal aging. Chronic kidney disease is diagnosed when eGFR is persistently below 60, or when a damage marker is present alongside a higher eGFR. Context and the urine test decide.
Why did my eGFR change without any symptoms?
Several harmless reasons are possible: dehydration on the day of the draw, a recent high-protein meal or intense workout, or the lab switching to the 2021 race-free CKD-EPI equation. A single change, especially a small one, is best confirmed with a repeat test rather than acted on immediately.
What's the most important test to add to eGFR?
The urine albumin-to-creatinine ratio (uACR). It detects protein leaking into the urine — frequently the earliest sign of kidney damage and something eGFR alone can miss. KDIGO guidelines stage kidney health using eGFR and albuminuria together.
Can I improve my eGFR?
You can often slow or stabilize decline by controlling blood pressure and blood sugar, avoiding kidney-stressing medications like frequent NSAIDs, staying well hydrated, and following a kidney-appropriate diet. Whether a specific number can rise depends on the cause. This should be managed with your clinician.
Do I need to fast for a creatinine/eGFR test?
Fasting isn't strictly required for creatinine, but a very high-protein meal or creatine supplements shortly before the draw can transiently raise creatinine and lower the estimate. It's often ordered with fasting labs, so follow the instructions for the full panel.
References
All citations verified against PubMed / publisher of record (see note below for this page's verification date).
- 1.Levey AS, Stevens LA, Schmid CH, et al. (CKD-EPI). (2009). A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine. 150(9):604-612. — The CKD-EPI creatinine equation used to compute eGFR from creatinine, age, and sex.PubMed →DOI →
- 2.Inker LA, Eneanya ND, Coresh J, et al. (2021). New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. New England Journal of Medicine. 385(19):1737-1749. — The 2021 race-free CKD-EPI equations and the value of adding cystatin C — basis for that section.PubMed →DOI →
- 3.Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 105(4S):S117-S314. — Source for the G1–G5 staging, the ≥ 3-month persistence requirement, and the eGFR-plus-albuminuria (G+A) framework.PubMed →DOI →
eGFR is an estimate and can be less accurate in people with atypical muscle mass; a cystatin C–based estimate can help in those cases. Chronic kidney disease is defined by persistence (≥ 3 months) and staged with albuminuria, not by a single eGFR. Every link opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-07-18.
By Steve Pinedo
Co-founder, Phi Longevity
Last updated: 2026-07-18
Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →